drugset / Trial / NCT00424567
Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures.
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this multi-center study is to obtain clinical data to substantiate that Aastrom TRC autologous bone marrow cells will regenerate bone in patients with established (appendicular skeletal) non union fractures, when used with one of the commonly employed commercially available allograft chip matrices.
Timeline
- Start
- 2003-10
- Primary completion
- —
- Completion
- 2007-06
Outcome
Outcome not reported
Stopped (Business): “Closed early for business reasons (not safety reasons)”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aastrom Tissue Repair Cells | Cell therapy | — | Other |